A Randomised, Multi-Centre, Placebo Controlled Trial of Fenofibrate for Treatment of Diabetic Macular Oedema with Economic Evaluation (FORTE Study)

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Our project aims to test if adding an inexpensive oral medication, fenofibrate, is effective at improving treatment of diabetic macular oedema. We will use a well-designed, adequately powered, multi-centred randomised placebo controlled trial to test if fenofibrate can treat currently untreatable forms of diabetic macular oedema, and if it can be combined with current treatments to improve outcomes and reduce costs and risks to patients.

Funded Activity Details

Start Date: 01-01-2016

End Date: 01-01-2020

Funding Scheme: Project Grants

Funding Amount: $1,588,132.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Ophthalmology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

blindness | diabetic retinopathy | intervention study | randomised controlled trial (RCT) | vision loss